Logo image of ONWD.BR

ONWARD MEDICAL (ONWD.BR) Stock Fundamental Analysis

EBR:ONWD - Euronext Brussels - NL0015000HT4 - Common Stock - Currency: EUR

4.27  -0.05 (-1.16%)

Fundamental Rating

2

Overall ONWD gets a fundamental rating of 2 out of 10. We evaluated ONWD against 55 industry peers in the Health Care Equipment & Supplies industry. The financial health of ONWD is average, but there are quite some concerns on its profitability. ONWD is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ONWD had negative earnings in the past year.
ONWD had a negative operating cash flow in the past year.
ONWD had negative earnings in each of the past 5 years.
In the past 5 years ONWD always reported negative operating cash flow.
ONWD.BR Yearly Net Income VS EBIT VS OCF VS FCFONWD.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

ONWD's Return On Assets of -46.92% is on the low side compared to the rest of the industry. ONWD is outperformed by 83.64% of its industry peers.
Looking at the Return On Equity, with a value of -74.34%, ONWD is doing worse than 76.36% of the companies in the same industry.
Industry RankSector Rank
ROA -46.92%
ROE -74.34%
ROIC N/A
ROA(3y)-57.55%
ROA(5y)-69.28%
ROE(3y)-112.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ONWD.BR Yearly ROA, ROE, ROICONWD.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

1.3 Margins

Looking at the Gross Margin, with a value of 268.83%, ONWD belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
ONWD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 268.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ONWD.BR Yearly Profit, Operating, Gross MarginsONWD.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K -40K -50K

More info and screens

4

2. Health

2.1 Basic Checks

ONWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ONWD has more shares outstanding
Compared to 5 years ago, ONWD has more shares outstanding
ONWD has a better debt/assets ratio than last year.
ONWD.BR Yearly Shares OutstandingONWD.BR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ONWD.BR Yearly Total Debt VS Total AssetsONWD.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of 0.19, we must say that ONWD is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.19, ONWD is doing worse than 72.73% of the companies in the same industry.
ONWD has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
ONWD's Debt to Equity ratio of 0.30 is in line compared to the rest of the industry. ONWD outperforms 54.55% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 0.19
ROIC/WACCN/A
WACC7.46%
ONWD.BR Yearly LT Debt VS Equity VS FCFONWD.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 6.85 indicates that ONWD has no problem at all paying its short term obligations.
ONWD has a Current ratio of 6.85. This is amongst the best in the industry. ONWD outperforms 100.00% of its industry peers.
ONWD has a Quick Ratio of 6.84. This indicates that ONWD is financially healthy and has no problem in meeting its short term obligations.
ONWD has a Quick ratio of 6.84. This is amongst the best in the industry. ONWD outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 6.85
Quick Ratio 6.84
ONWD.BR Yearly Current Assets VS Current LiabilitesONWD.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 23.37% over the past year.
Looking at the last year, ONWD shows a very strong growth in Revenue. The Revenue has grown by 236.76%.
EPS 1Y (TTM)23.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30.08%
Revenue 1Y (TTM)236.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to decrease by -7.30% on average over the next years.
ONWD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 148.02% yearly.
EPS Next Y-20.73%
EPS Next 2Y-7.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year503.2%
Revenue Next 2Y325.8%
Revenue Next 3YN/A
Revenue Next 5Y148.02%

3.3 Evolution

ONWD.BR Yearly Revenue VS EstimatesONWD.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2028 2029 2030 2031 2032 50M 100M 150M
ONWD.BR Yearly EPS VS EstimatesONWD.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ONWD. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ONWD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ONWD.BR Price Earnings VS Forward Price EarningsONWD.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ONWD.BR Per share dataONWD.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1

4.3 Compensation for Growth

ONWD's earnings are expected to decrease with -7.30% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.3%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ONWD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ONWARD MEDICAL

EBR:ONWD (7/21/2025, 7:00:00 PM)

4.27

-0.05 (-1.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-01 2025-04-01/amc
Earnings (Next)N/A N/A
Inst Owners30.04%
Inst Owner ChangeN/A
Ins Owners16.07%
Ins Owner ChangeN/A
Market Cap190.66M
Analysts86
Price Target13.67 (220.14%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-8.97%
PT rev (3m)-5.1%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.53%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2476.05
P/FCF N/A
P/OCF N/A
P/B 3.97
P/tB 5.07
EV/EBITDA N/A
EPS(TTM)-0.92
EYN/A
EPS(NY)-1.1
Fwd EYN/A
FCF(TTM)-0.71
FCFYN/A
OCF(TTM)-0.71
OCFYN/A
SpS0
BVpS1.08
TBVpS0.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -46.92%
ROE -74.34%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 268.83%
FCFM N/A
ROA(3y)-57.55%
ROA(5y)-69.28%
ROE(3y)-112.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 16.7%
Cap/Sales 194.81%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.85
Quick Ratio 6.84
Altman-Z 0.19
F-Score6
WACC7.46%
ROIC/WACCN/A
Cap/Depr(3y)43.86%
Cap/Depr(5y)180.36%
Cap/Sales(3y)362.35%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%30.08%
EPS Next Y-20.73%
EPS Next 2Y-7.3%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)236.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year503.2%
Revenue Next 2Y325.8%
Revenue Next 3YN/A
Revenue Next 5Y148.02%
EBIT growth 1Y1.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-31.65%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.57%
OCF growth 3YN/A
OCF growth 5YN/A